ConductScience.org, home

Paper7752190

Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)

Pettit GR and 6 others. J Med Chem, 1995. Cited by 302 papers, by iCite.

Cite this record

ConductScience Library. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a). Papers, record 7752190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7752190

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)
PubMed
Journal
J Med Chem
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
302
iCite
Relative citation ratio, by iCite
8.92
iCite
Revised in PubMed
2019-07-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pettit GRG R
2Singh SBS B
3Boyd MRM R
4Hamel EE
5Pettit RKR K
6Schmidt JMJ M
7Hogan FF

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, PhytogenicMajor topic
Plants, MedicinalMajor topic
StilbenesMajor topic
Anti-Bacterial Agents
Drug Screening Assays, Antitumor
Microbial Sensitivity Tests
Neisseria gonorrhoeae
Structure-Activity Relationship
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 16049-05-12NCI NIH HHSUnited StatesPubMedPubMed
CA 44344-01A1-06NCI NIH HHSUnited StatesPubMedPubMed
N01-CM-97262NCI NIH HHSUnited StatesN01CM097262PubMed and NIHNIH RePORTER
R01CA016049NIHNIH RePORTER
R35CA044344NIHNIH RePORTER

Download CSV of grants

Cited by65

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 302 citations.

PMIDTitleJournalYearIn PapersSource
40927638Targeting Tumor-Associated Hypoxia with Bioreductively Activatable Prodrug Conjugates Derived from Dihydronaphthalene, Benzosuberene, and Indole-based Inhibitors of Tubulin Polymerization.RSC Med Chem2025https://conductscience.org/library/papers/40927638PubMed
40427352Alternative Agents to Colcemid for Obtaining High-Quality Metaphase Spreads.Animals (Basel)2025https://conductscience.org/library/papers/40427352PubMed
39990814Design, synthesis, molecular docking and anticancer activity of benzothiazolecarbohydrazide-sulfonate conjugates: insights into ROS-induced DNA damage and tubulin polymerization inhibition.RSC Adv2025https://conductscience.org/library/papers/39990814PubMed
39970877First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors.Cell Rep Med2025https://conductscience.org/library/papers/39970877PubMed
39861179
(E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer.
Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/39861179PubMed
39860187Synthesis and Biological Evaluation of New cis-Restricted Triazole Analogues of Combretastatin A-4.Molecules2025https://conductscience.org/library/papers/39860187PubMed
38659489Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management.World J Gastroenterol2024https://conductscience.org/library/papers/38659489PubMed
380838803-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents.J Enzyme Inhib Med Chem2024https://conductscience.org/library/papers/38083880PubMed
37111767Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent.Pharmaceutics2023https://conductscience.org/library/papers/37111767PubMed
36830175Ethnopharmacology, Antimicrobial Potency, and Phytochemistry of African Combretum and Pteleopsis Species (Combretaceae): A Review.Antibiotics (Basel)2023https://conductscience.org/library/papers/36830175PubMed
36364041Copper-Catalyzed Diboron-Mediated cis-Semi-Hydrogenation of Alkynes under Facile Conditions.Molecules2022https://conductscience.org/library/papers/36364041PubMed
36320328An organometallic analogue of combretastatin A-4 and its apoptosis-inducing effects on lymphoma, leukemia and other tumor cells in vitro.RSC Med Chem2022https://conductscience.org/library/papers/36320328PubMed
36142133The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma.Int J Mol Sci2022https://conductscience.org/library/papers/36142133PubMed
35628467Photopharmacology of Antimitotic Agents.Int J Mol Sci2022https://conductscience.org/library/papers/35628467PubMed
35539660Diaryl ethers synthesis: nano-catalysts in carbon-oxygen cross-coupling reactions.RSC Adv2018https://conductscience.org/library/papers/35539660PubMed
35510306Optochemical Control of Therapeutic Agents through Photocatalyzed Isomerization.Angew Chem Int Ed Engl2022https://conductscience.org/library/papers/35510306PubMed
35263505Cyclobutanes in Small-Molecule Drug Candidates.ChemMedChem2022https://conductscience.org/library/papers/35263505PubMed
34959731New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3H)-benzothiazolones.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34959731PubMed
34890803Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.Drug Discov Today2022https://conductscience.org/library/papers/34890803PubMed
34832895New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34832895PubMed

See all 65 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7752190

GET https://conductscience.org/api/papers/v1/7752190/cited_by?page=2